Because baseline CD4+ TEM expansion was observed in patients with metastatic disease, but not in patients with fully resected melanoma, it is possible that disseminated melanoma promotes low-level CMV reactivation, perhaps through compromised T cell immunity, which then stimulates virus-specific CD4+ T cell expansion. Here, CD4 is linked to metastatic neoplasm.